NCT05263921
- Conditions
- Bioavailability, COVID-19, Coronaviridae Infections, +10 more
- Locations
-
- Pfizer Clinical Research Unit - New Haven New Haven, Connecticut, United States
Clinical trial condition
Explore clinical trials studying Bioavailability. Study availability and eligibility vary by location and protocol.
NCT05263921
NCT06214338
NCT04139928
NCT05826899
NCT06043739
NCT05967377
NCT05835258
NCT05646368
NCT05840848
NCT03443076